US5652118A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Nucleic acid encoding a novel morphogenic protein, OP-3
Assignee: Stryker Corp
•
Filing: 1995-06-07
•
Granted: 1997-07-29
•
Expires: 2015-06-07
Abstract
Abstract Disclosed are (1) nucleic acid and amino acid sequences for a novel morphogenic protein; (2) methods for producing and expressing the protein in a biologically active form; and (3) methods for utilizing the protein to induce tissue morphogenesis in a mammal, including methods for increasing a progenitor cell population in a mammal, methods for stimulating progenitor cells to differentiate and maintain their differentiated phenotype in vivo or in vitro, methods for inducing tissue-specific growth in vivo and methods for the replacement of diseased or damaged tissue in vivo.
Inventors
- 👤 Engin Ozkaynak
- 👤 Hermann Oppermann
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 16:07
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A01; A01N; A01N1/00; A01N1/10; A01N1/12; A01N1/122; A01N1/126; A61K38/1703; A61K38/18; A61K38/1875; A61K6/00; A61K6/50; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61L27/24; C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/51; C07K14/575; C07K14/62; C07K14/625; C07K16/00; C07K16/18; C07K16/22; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; C12Q1/6881; A61F; A61F2310/00; A61F2310/00005; A61F2310/00365; A61K48/00; C12Q2600/00; C12Q2600/156; C12Q2600/158; G; G01; G01N; G01N2500/00; G01N2500/10
Claims Analysis
Total Claims: 31
Claim 1
Independent Claim
30 words
Substantially pure nucleic acid encoding an OP3 polypeptide chain, the sequence of said nucleic acid comprising bases 1 to 1674 of Seq. ID No. 1, or a conservative variant thereof.
Claim 2
Dependent Claim
30 words
Substantially pure nucleic acid encoding an OP3 polypeptide chain, the sequence of said nucleic acid comprising bases 1 to 1674 of Seq. ID No. 1, or a conservative variant thereof.
Claim 3
Dependent Claim
50 words
Substantially pure nucleic acid the sequence of which comprises a nucleotide sequence encoding a morphogen prodomain polypeptide, wherein said nucleotide sequence hybridizes, under stringent conditions, to a sequence complementary to a nucleic acid sequence consisting of bases 120 to 440 of Seq. ID No. 1, or a conservative variant thereof.
Claim 4
Dependent Claim
50 words
Substantially pure nucleic acid the sequence of which comprises a nucleotide sequence encoding a morphogen prodomain polypeptide, wherein said nucleotide sequence hybridizes, under stringent conditions, to a sequence complementary to a nucleic acid sequence consisting of bases 120 to 440 of Seq. ID No. 1, or a conservative variant thereof.
Claim 5
Dependent Claim
40 words
Substantially pure nucleic acid the sequence of which comprises a nucleotide sequence encoding a morphogen prodomain polypeptide, said nucleotide sequence comprising bases 120 to 848, or bases 120 to 857, of Seq. ID No. 1, or a conservative variant thereof.
Claim 6
Dependent Claim
40 words
Substantially pure nucleic acid the sequence of which comprises a nucleotide sequence encoding a morphogen prodomain polypeptide, said nucleotide sequence comprising bases 120 to 848, or bases 120 to 857, of Seq. ID No. 1, or a conservative variant thereof.
Claim 7
Dependent Claim
50 words
Substantially pure nucleic acid encoding a polypeptide, said nucleic acid having a sequence comprising at least bases 960 to 1265 of Seq. ID No. 1, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 8
Dependent Claim
50 words
Substantially pure nucleic acid encoding a polypeptide, said nucleic acid having a sequence comprising at least bases 960 to 1265 of Seq. ID No. 1, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 9
Dependent Claim
43 words
Substantially pure nucleic acid of claim 4, said nucleic acid having a sequence further comprising bases 858 to 959 of Seq. ID No. 1, or a conservative variant thereof, located 5' to and adjoining bases 960 to 1265 of Seq. ID No. 1.
Claim 10
Dependent Claim
43 words
Substantially pure nucleic acid of claim 4, said nucleic acid having a sequence further comprising bases 849 to 959 of Seq. ID No. 1, or a conservative variant thereof, located 5' to and adjoining bases 960 to 1265 of Seq. ID No. 1.
Claim 11
Dependent Claim
43 words
Substantially pure nucleic acid of claim 4, said nucleic acid having a sequence further comprising bases 120 to 959 of Seq. ID No. 1, or a conservative variant thereof, located 5' to and adjoining bases 960 to 1265 of Seq. ID No. 1.
Claim 12
Dependent Claim
43 words
Substantially pure nucleic acid of claim 4, said nucleic acid having a sequence further comprising bases 69 to 959 of Seq. ID No. 1, or a conservative variant thereof, located 5' to and adjoining bases 960 to 1265 of Seq. ID No. 1.
Claim 13
Dependent Claim
66 words
A vector comprising a nucleic acid insert encoding a polypeptide the sequence of said insert comprising at least bases 960 to 1265 of Seq. ID No. 1, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue, said nucleic acid insert being in operative association with an expression control sequence therefor.
Claim 14
Dependent Claim
66 words
A vector comprising a nucleic acid insert encoding a polypeptide the sequence of said insert comprising at least bases 960 to 1265 of Seq. ID No. 1, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue, said nucleic acid insert being in operative association with an expression control sequence therefor.
Claim 15
Dependent Claim
9 words
A cell transformed with the vector of claim 9.
Claim 16
Dependent Claim
62 words
A host cell transformed with nucleic acid encoding a polypeptide in operative association with an expression control sequence therefor, said nucleic acid having a sequence comprising at least bases 960 to 1265 of Seq. ID No. 1, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 17
Dependent Claim
62 words
A host cell transformed with nucleic acid encoding a polypeptide in operative association with an expression control sequence therefor, said nucleic acid having a sequence comprising at least bases 960 to 1265 of Seq. ID No. 1, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 18
Independent Claim
99 words
A method of producing a morphogenically active protein comprising the steps of: (a) transfecting cells with a nucleic acid encoding a polypeptide, the amino acid sequence of said polypeptide chain comprising at least amino acid residues 298 to 399 of Seq. ID No. 2, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue; (b) culturing said cells in a suitable culture medium; (c) expressing said polypeptide chain from said nucleic acid; and (d) isolating and purifying said dimeric protein from said culture medium.
Claim 19
Independent Claim
99 words
A method of producing a morphogenically active protein comprising the steps of: (a) transfecting cells with a nucleic acid encoding a polypeptide, the amino acid sequence of said polypeptide chain comprising at least amino acid residues 298 to 399 of Seq. ID No. 2, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue; (b) culturing said cells in a suitable culture medium; (c) expressing said polypeptide chain from said nucleic acid; and (d) isolating and purifying said dimeric protein from said culture medium.
Claim 20
Dependent Claim
69 words
Substantially pure nucleic acid encoding a first polypeptide, the amino acid sequence of which comprises residues 298 to 399 of Seq. ID No. 2, or a conservative variant thereof, such that a dimeric protein comprising said first polypeptide and a second polypeptide, the sequence of which comprises an amino acid sequence defined by Generic Sequence 8, Seq. ID No. 13, induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 21
Dependent Claim
69 words
Substantially pure nucleic acid encoding a first polypeptide, the amino acid sequence of which comprises residues 298 to 399 of Seq. ID No. 2, or a conservative variant thereof, such that a dimeric protein comprising said first polypeptide and a second polypeptide, the sequence of which comprises an amino acid sequence defined by Generic Sequence 8, Seq. ID No. 13, induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 22
Dependent Claim
27 words
Substantially pure nucleic acid of claim 13 encoding said first polypeptide, the amino acid sequence of which comprises residues 298 to 399 of Seq. ID No. 2.
Claim 23
Dependent Claim
45 words
Substantially pure nucleic acid of claim 13 encoding said first polypeptide, the amino acid sequence of which comprises a conservative variant of residues 298 to 399 of Seq. ID No. 2 wherein a tyrosine, histidine, isoleucine or serine residue is substituted for cysteine residue 338.
Claim 24
Dependent Claim
41 words
Substantially pure nucleic acid of claim 13 encoding said first polypeptide, the amino acid sequence of which comprises a conservative variant of residues 298 to 399 of Seq. ID No. 2 wherein a tryptophan residue is substituted for serine residue 315.
Claim 25
Dependent Claim
48 words
Substantially pure nucleic acid encoding a polypeptide, the amino acid sequence of which comprises residues 298 to 399 of Seq. ID No. 2, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 26
Dependent Claim
48 words
Substantially pure nucleic acid encoding a polypeptide, the amino acid sequence of which comprises residues 298 to 399 of Seq. ID No. 2, or a conservative variant thereof, such that a dimeric protein comprising a pair of said polypeptides induces tissue-specific morphogenesis at least of mammalian bone tissue.
Claim 27
Dependent Claim
31 words
Substantially pure nucleic acid encoding a promorphogen polypeptide, the amino acid sequence of which comprises at least residues 298 to 339 of Seq. ID No. 2, or a conservative variant thereof.
Claim 28
Dependent Claim
31 words
Substantially pure nucleic acid encoding a promorphogen polypeptide, the amino acid sequence of which comprises at least residues 298 to 339 of Seq. ID No. 2, or a conservative variant thereof.
Claim 29
Dependent Claim
34 words
Substantially pure nucleic acid of claim 18 encoding a promorphogen polypeptide, the amino acid sequence of which comprises at least residues 264 to 339 of Seq. ID No. 2, or a conservative variant thereof.
Claim 30
Dependent Claim
34 words
Substantially pure nucleic acid of claim 18 encoding a promorphogen polypeptide, the amino acid sequence of which comprises at least residues 261 to 339 of Seq. ID No. 2, or a conservative variant thereof.
Claim 31
Dependent Claim
32 words
Substantially pure nucleic acid of claim 18 encoding a promorphogen polypeptide, the amino acid sequence of which comprises residues 18 to 339 of Seq. ID No. 2, or a conservative variant thereof.
References Cited (Backward Citations)
EP0148155A2
Cited
WO1988000205A1
Cited
US5141905A
Cited
US5013649A
Cited
US4877864A
Cited
US5091513A
Cited
US5001230A
Cited
WO1989009788A2
Cited
WO1989009787A2
Cited
WO1989010409A1
Cited
US4968590A
Cited
US5108753A
Cited
US5011691A
Cited
US5106626A
Cited
WO1990003733A1
Cited
US4975526A
Cited
US5002965A
Cited
EP0416578A2
Cited
WO1992007073A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-07-28 | 2001-01-27 | 2001-07-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-07-28 | 2005-01-27 | 2005-07-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-07-28 | 2009-01-27 | 2009-07-29 | $7700.00 | Window Closed / Lapsed |